The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, yet its future within the broader market now triggers questions about long-term returns . Alternative versions are diminishing market share, leading to worries that supporting companies significantly dependent to Viagra's once-dominant standing could be a dangerous